Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and materials for assessing homologous recombination deficiency

Methods and materials for assessing homologous recombination deficiency

US Patent 10400287 · Granted Sep 3, 2019

Estimated economic value: $36,869,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and materials for assessing homologous recombination deficiency2025
Methods and materials for assessing homologous recombination deficiency2025
Methods and materials for assessing homologous recombination deficiency2025
Methods and materials for assessing homologous recombination deficiency2025
Hereditary cancer genes2025
Adjusted multi-biomarker disease activity score for inflammatory disease assessm2025
Genes and gene signatures for diagnosis and treatment of melanoma2025
Methods and materials for assessing homologous recombination deficiency2025
Methods and materials for assessing homologous recombination deficiency2025
Methods and materials for assessing homologous recombination deficiency2025
Methods and materials for assessing homologous recombination deficiency2025
Method of using biomarkers and clinical variables for predicting chemotherapy be2024